Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kratz

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Die Medizinische Welt|September 26, 1975
[Laparoscopy. Results and experiences]B Leinweber, M Korte, F Kratz, et al.
Pharmaceutical Research|May 5, 2001
Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopyU Beyer, B Rothern-Rutishauser, C Unger, et al.
Metal-Based Drugs|January 1, 1994
Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and ApolactoferrinF Kratz, B K Keppler, L Messori, et al.
Metal-Based Drugs|January 1, 1996
Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell LineF Kratz, B K Keppler, M Hartmann, et al.
Die Medizinische Welt|March 11, 1983
[Effect of cimetidine and ranitidine on drug metabolism of the liver]J Homann, F Paul, F Kratz, et al.
Journal of Drug Targeting|May 1, 2001
In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma modelF Kratz, T Roth, I Fichiner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2008
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moietiesM Baglioni, L Fiume, L Bolondi, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugatesF Kratz, J Drevs, G Bing, et al.
Journal of Medicinal Chemistry|April 20, 2001
Novel peptide conjugates for tumor-specific chemotherapyM Langer, F Kratz, B Rothen-Rutishauser, et al.
Investigational New Drugs|January 17, 2009
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma modelR Graeser, N Esser, H Unger, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Die Medizinische Welt|September 26, 1975
[Laparoscopy. Results and experiences]B Leinweber, M Korte, F Kratz, et al.
Pharmaceutical Research|May 5, 2001
Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopyU Beyer, B Rothern-Rutishauser, C Unger, et al.
Metal-Based Drugs|January 1, 1994
Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and ApolactoferrinF Kratz, B K Keppler, L Messori, et al.
Metal-Based Drugs|January 1, 1996
Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell LineF Kratz, B K Keppler, M Hartmann, et al.
Die Medizinische Welt|March 11, 1983
[Effect of cimetidine and ranitidine on drug metabolism of the liver]J Homann, F Paul, F Kratz, et al.
Journal of Drug Targeting|May 1, 2001
In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma modelF Kratz, T Roth, I Fichiner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2008
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moietiesM Baglioni, L Fiume, L Bolondi, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugatesF Kratz, J Drevs, G Bing, et al.
Journal of Medicinal Chemistry|April 20, 2001
Novel peptide conjugates for tumor-specific chemotherapyM Langer, F Kratz, B Rothen-Rutishauser, et al.
Investigational New Drugs|January 17, 2009
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma modelR Graeser, N Esser, H Unger, et al.
Pageof 5